Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 7 | 9 | +2 |
| Shares | 144.4K | 116.6K | −27.8K (−19.3%) |
| Value | $512.7K | $209.9K | −$302.8K (−59.1%) |
New holders (4)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 68,993 | $124.2K | 0.02% |
| Boothbay Fund Management, LLC | 20,360 | $36.6K | 0.00% |
| Geode Capital Management, LLC | 14,444 | $26.0K | 0.00% |
| Citigroup Inc | 1 | $2 | 0.00% |
Sold out (2)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Connective Capital Management, LLC | 100,535 | $356.9K |
| DRW Securities, LLC | 42,830 | $152.0K |